{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:49:33Z","timestamp":1771933773724,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.112083","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T21:12:30Z","timestamp":1713733950000},"page":"112083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM\/ceramide pathway"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0972-6709","authenticated-orcid":false,"given":"Na","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-7082","authenticated-orcid":false,"given":"Jinyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YanPing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4950-9742","authenticated-orcid":false,"given":"Zhenhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.intimp.2024.112083_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/v9090243","article-title":"Regulation of apoptosis during flavivirus infection","volume":"9","author":"Okamoto","year":"2017","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.intimp.2024.112083_b0010","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"21","key":"10.1016\/j.intimp.2024.112083_b0015","doi-asserted-by":"crossref","first-page":"E657","DOI":"10.1503\/cmaj.171341","article-title":"Japanese encephalitis","volume":"190","author":"Keng","year":"2018","journal-title":"CMAJ"},{"issue":"12","key":"10.1016\/j.intimp.2024.112083_b0020","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJMc1916977","article-title":"Guillain-Barr\u00e9 syndrome associated with JEV infection","volume":"383","author":"Wang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7503","key":"10.1016\/j.intimp.2024.112083_b0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.intimp.2024.112083_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/v11100912","article-title":"Sphingolipids as potential therapeutic targets against enveloped human RNA viruses","volume":"11","author":"Yager","year":"2019","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.intimp.2024.112083_b0035","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JVI.02499-09","article-title":"Involvement of ceramide in the propagation of Japanese encephalitis virus","volume":"84","author":"Tani","year":"2010","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112083_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115676","article-title":"Ceramide and related molecules in viral infections","volume":"22","author":"Beckmann","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2024.112083_b0045","doi-asserted-by":"crossref","first-page":"e2963","DOI":"10.1038\/cddis.2017.360","article-title":"Acid sphingomyelinase mediates human CD4 T-cell signaling: potential roles in T-cell responses and diseases","volume":"8","author":"Bai","year":"2017","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.intimp.2024.112083_b0050","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.20151517","article-title":"Human T cell responses to Japanese encephalitis virus in health and disease","volume":"213","author":"Turtle","year":"2016","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112083_b0055","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1080\/21505594.2021.1899674","article-title":"Pathogenicity and virulence of Japanese encephalitis virus: neuroinflammation and neuronal cell damage","volume":"12","author":"Ashraf","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.intimp.2024.112083_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcdb.2015.04.011","article-title":"Claudins and pathogenesis of viral infection","volume":"42","author":"Tawar","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112083_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092175","article-title":"Sphingolipids: effectors and Achilles heals in viral infections?","volume":"10","author":"Schneider-Schaulies","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.112083_b0070","article-title":"Keep your friends close, but your enemies closer: role of acid sphingomyelinase during infection and host response","volume":"7","author":"Chung","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.intimp.2024.112083_b0075","doi-asserted-by":"crossref","first-page":"37829","DOI":"10.1038\/srep37829","article-title":"Sphingomyelin generated by sphingomyelin synthase 1 is involved in attachment and infection with Japanese encephalitis virus","volume":"6","author":"Taniguchi","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.intimp.2024.112083_b0080","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1515\/hsz-2018-0200","article-title":"The role of acid sphingomyelinase and modulation of sphingolipid metabolism in bacterial infection","volume":"399","author":"Simonis","year":"2018","journal-title":"Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112083_b0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.virol.2015.06.015","article-title":"Differential utilisation of ceramide during replication of the flaviviruses West Nile and dengue virus","volume":"484","author":"Aktepe","year":"2015","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.intimp.2024.112083_b0090","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1128\/JVI.02061-14","article-title":"The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis","volume":"88","author":"Mart\u00edn-Acebes","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112083_b0095","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.1038\/s41598-018-29329-2","article-title":"Determination of system level alterations in host transcriptome due to Zika virus (ZIKV) infection in retinal pigment epithelium","volume":"8","author":"Singh","year":"2018","journal-title":"Sci. Rep."},{"issue":"6\u20137","key":"10.1016\/j.intimp.2024.112083_b0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1515\/hsz-2014-0273","article-title":"Sphingolipids in viral infection","volume":"396","author":"Schneider-Schaulies","year":"2015","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2024.112083_b0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5483\/BMBRep.2020.53.1.278","article-title":"Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy","volume":"53","author":"Lee","year":"2020","journal-title":"BMB Rep."},{"key":"10.1016\/j.intimp.2024.112083_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100701","article-title":"Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells","volume":"296","author":"Carpinteiro","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2024.112083_b0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood.2021010685","article-title":"SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase","volume":"138","author":"Wang","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2024.112083_b0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41380-021-01309-5","article-title":"The acid sphingomyelinase\/ceramide system in COVID-19","volume":"27","author":"Kornhuber","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.intimp.2024.112083_b0125","doi-asserted-by":"crossref","first-page":"e13101","DOI":"10.1111\/sji.13101","article-title":"Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease","volume":"94","author":"Danieli","year":"2021","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112083_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13223-021-00609-3","article-title":"Potential therapeutic approach of intravenous immunoglobulin against COVID-19","volume":"17","author":"Kolahchi","year":"2021","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2024.112083_b0135","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12026-014-8580-6","article-title":"Intravenous immunoglobulin exerts reciprocal regulation of Th1\/Th17 cells and regulatory T cells in Guillain-Barr\u00e9 syndrome patients","volume":"60","author":"Maddur","year":"2014","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.112083_b0140","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s13311-021-01117-3","article-title":"Novel immunological and therapeutic insights in Guillain-Barr\u00e9 syndrome and CIDP","volume":"18","author":"Querol","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.intimp.2024.112083_b0145","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112083_b0150","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/ene.14501","article-title":"Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"28","author":"Kuitwaard","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112083_b0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1756285614563056","article-title":"Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction","volume":"8","author":"Hadden","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"3","key":"10.1016\/j.intimp.2024.112083_b0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2141.2006.06185.x","article-title":"Intravenous immunoglobulin (IVIG)-mediated neutralisation of C5a: a direct mechanism of IVIG in the maintenance of a high Fc gammaRIIB to Fc gammaRIII expression ratio on macrophages","volume":"134","author":"Konrad","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.112083_b0165","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1007\/s10875-014-0019-2","article-title":"Natural autoantibodies to Fc\u03b3 receptors in intravenous immunoglobulins","volume":"34","author":"Bouhlal","year":"2014","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112083_b0170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1423-0410.2009.01217.x","article-title":"In vitro comparison of the complement-scavenging capacity of different intravenous immunoglobulin preparations","volume":"97","author":"Spycher","year":"2009","journal-title":"Vox Sang."},{"issue":"1","key":"10.1016\/j.intimp.2024.112083_b0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jnnp.2010.205856","article-title":"IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy","volume":"82","author":"Yuki","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.intimp.2024.112083_b0180","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1067\/mai.2003.1380","article-title":"IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy","volume":"111","author":"Binstadt","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112083_b0185","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3389\/fimmu.2020.01660","article-title":"High-dose intravenous immunoglobulins in the treatment of severe acute viral pneumonia: the known mechanisms and clinical effects","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.112083_b0190","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jneuroim.2010.08.023","article-title":"IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN","volume":"229","author":"Piepers","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2024.112083_b0195","doi-asserted-by":"crossref","unstructured":"S. Keddie, F. Eftimov, L.H. van den Berg, R. Brassington, R.J. de Haan, I.N. van Schaik, Immunoglobulin for multifocal motor neuropathy, Cochrane Database Syst Rev 1 (2022) CD004429.","DOI":"10.1002\/14651858.CD004429.pub3"},{"issue":"5","key":"10.1016\/j.intimp.2024.112083_b0200","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10495-015-1101-9","article-title":"The emerging role of acid sphingomyelinase in autophagy","volume":"20","author":"Perrotta","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2024.112083_b0205","doi-asserted-by":"crossref","unstructured":"A. Kumar, J. Kalita, R.A. Sinha, G. Singh, A. B, M. Shukla, S. Tiwari, T.N. Dhole, U.K. Misra, Impaired Autophagy Flux is Associated with Proinflammatory Microglia Activation Following Japanese Encephalitis Virus Infection, Neurochem Res 45(9) (2020) 2184-2195.","DOI":"10.1007\/s11064-020-03080-5"},{"issue":"3","key":"10.1016\/j.intimp.2024.112083_b0210","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00705-021-05283-9","article-title":"Autophagy inhibitors alleviate Japanese encephalitis virus-induced cerebral inflammation in mice","volume":"167","author":"Zhang","year":"2022","journal-title":"Arch. Virol"},{"issue":"3","key":"10.1016\/j.intimp.2024.112083_b0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2013.08.003","article-title":"Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase","volume":"24","author":"Petersen","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2024.112083_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100994","article-title":"Pathobiology of Japanese encephalitis virus infection","volume":"81","author":"Sharma","year":"2021","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.intimp.2024.112083_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113385","article-title":"Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies","volume":"331","author":"Stubbs","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2024.112083_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113272","article-title":"Biology of the human blood-nerve barrier in health and disease","volume":"328","author":"Ubogu","year":"2020","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.intimp.2024.112083_b0235","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.4049\/jimmunol.1400346","article-title":"CD39 and CD161 modulate Th17 responses in Crohn's disease","volume":"193","author":"Bai","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112083_b0240","doi-asserted-by":"crossref","first-page":"1002915","DOI":"10.3389\/fphar.2022.1002915","article-title":"How sphingolipids affect T cells in the resolution of inflammation","volume":"13","author":"Hartel","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112083_b0245","doi-asserted-by":"crossref","first-page":"e1828","DOI":"10.1038\/cddis.2015.178","article-title":"Role of acid sphingomyelinase bioactivity in human CD4+ T-cell activation and immune responses","volume":"6","author":"Bai","year":"2015","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.intimp.2024.112083_b0250","doi-asserted-by":"crossref","first-page":"e0122608","DOI":"10.1371\/journal.pone.0122608","article-title":"A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal","volume":"10","author":"Rayamajhi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112083_b0255","doi-asserted-by":"crossref","unstructured":"W. Miao, J. Guo, S. Zhang, N. Shen, X. Shang, F. Liu, W. Lu, J. Xu, J. Teng, The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis, Front Neurol 12 (2021) 711674.","DOI":"10.3389\/fneur.2021.711674"},{"issue":"5","key":"10.1016\/j.intimp.2024.112083_b0260","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/INF.0000000000003861","article-title":"Geographic expansion of Japanese encephalitis virus to Australia: neuroinflammatory sequelae and consideration of immunomodulation","volume":"42","author":"Cole","year":"2023","journal-title":"Pediatr. Infect. Dis. J."}],"updated-by":[{"DOI":"10.1016\/j.intimp.2024.112270","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T20:07:03Z","timestamp":1715630823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924006015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":52,"alternative-id":["S1567576924006015"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112083","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.intimp.2024.112270","asserted-by":"object"}]},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM\/ceramide pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112083"}}